-+ 0.00%
-+ 0.00%
-+ 0.00%

ASP Isotopes publishes corporate presentation on isotope enrichment platform, commercialization milestones

PUBT·04/13/2026 13:17:49
Listen to the news
ASP Isotopes publishes corporate presentation on isotope enrichment platform, commercialization milestones
  • ASP Isotopes outlined plans to scale isotope-enrichment capacity across electronics, nuclear medicine, and nuclear energy end markets.
  • Operational targets include first enriched Silicon-28 shipments in Q2 2026.
  • Management targets initial commercial shipments of Carbon-14 around mid-2026, subject to feedstock delivery.
  • Ytterbium-176 initial commercial shipments are targeted around mid-2026 to Q3 2026.
  • Company reiterated a management EBITDA target of more than $300 million in 2031.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief on April 13, 2026, and is solely responsible for the information contained therein.